(Press-News.org) Low doses of fluoxetine - better known as the anti-depressant Prozac - could hold the key to preventing PMS symptoms, an international team of researchers has found.
Up to 80 per cent of women are thought to suffer from premenstrual syndrome (PMS), which can be a debilitating condition with symptoms such as anxiety, irritability, fatigue, sleep deprivation and increased sensitivity to pain.
PMS appears to be triggered by the fall in secretion of the ovarian sex steroid hormone progesterone that occurs towards the end of the menstrual cycle and leads to a decline in its breakdown product allopregnanolone, which acts in the brain as a potent sedative and tranquilising agent.
In other words, women with PMS are undergoing a type of drug withdrawal response from an in-built, tranquilising steroid chemical in their brains.
Scientists from the University of Bristol, UCL and the University of Sao Paolo-Ribeirão Preto in Brazil have shown in rats that the anti-depressant can inhibit a specific enzyme in the brain and could be used to alleviate symptoms of progesterone withdrawal such as PMS and possibly also postnatal depression.
The new research shows that antidepressants such as fluoxetine inhibit the enzyme, which deactivates allopregnanolone, therefore maintaining the chemical balance of this in-built tranquiliser in the brain.
Importantly, the researchers were able to demonstrate this effect on the same enzyme found in the human brain.
The new research, a collaboration between Dr Thelma Lovick from the University of Bristol, Dr Jonathan Fry from UCL and Professor Marcus Brandão from the University of Sao Paolo-Ribeirão Preto in Brazil, was funded by the Medical Research Council in the UK and CNPq in Brazil.
Dr Lovick, from the School of Physiology and Pharmacology at the University of Bristol, said: "The work is important because it introduces the possibility for targeted, intermittent therapy for PMS in women, with minimal side effects."
Human trials are expected to get underway soon in Brazil.In addition, with an identified target, there is also the possibility of developing new drugs with a more specific mode of action than the antidepressants for the treatment of PMS.
A paper published in the journal European Neuropsychopharmacology, coupled with the team's recent findings published in the British Journal of Pharmacology, show that short-term treatment with a low dose of fluoxetine immediately prior to the rat's premenstrual period not only raised brain allopregnanolone and prevented the development of PMS-like symptoms but also blocked the increase in excitability of brain circuits involved in mediating the stress and fear responses that normally occur during this phase of the cycle.
Surprisingly, in the case of rats, the effective dose of fluoxetine was well below that needed to produce antidepressant effects. The effects of the drug were seen within hours of administration, unlike the two to three weeks of treatment normally needed when fluoxetine is used to treat depression.
INFORMATION:
Papers
'Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrus cycle-linked increase in stress sensitivity in female rats' by AJ Devall, JM Santos, JP Fry, JW Honour, ML Brandão and TA Lovick in European Neuropsychopharmacology.
'Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase' by JP Fry, KY Li, AJ Devall, S Cockcroft, JW Honour, TA Lovick in the British Journal of Pharmacology
In 2012 the Mars Science Laboratory landed in the fascinating Gale crater. The Gale crater is of such great interest because of the 5.5 km high mountain of layered materials in the middle. This material tells an intricate story of the history of Mars, perhaps spanning much of the existence of this mysterious planet.
Once positioned, the Curiosity rover began field studies on its drive toward Aeolis Mons (also unofficially known as Mount Sharp), the central peak within the crater. Curiosity has travelled more than 9.4 km so far and during its trip up the mountain, Curiosity ...
A new advance in biomedical research at the University of Leicester could have potential in the future to assist with tackling diseases and conditions associated with ageing - as well as in treating cancer.
The research, which has shown promise in clinical samples, has been published in the prestigious scientific journal, Cell Death and Disease.
The group of scientists coordinated by Dr Salvador Macip from the Mechanisms of Cancer and Ageing Lab and the Department of Biochemistry of the University of Leicester carried out the study to find new ways of identifying old ...
Insects are full of marvels - and this is certainly the case with a beetle from the Tenebrionind family, found in the extreme conditions of the Namib desert. Now, a team of scientists has demonstrated that such insects can collect dew on their backs - and not just fog as previously thought. This is made possible by the wax nanostructure on the surface of the beetle's elytra. These findings by José Guadarrama-Cetina, then working at ESPCI ParisTech, France - on leave from the University of Navarra, in Spain - and colleagues were recently published in EPJ E. They bring ...
MOUNT VERNON, WA - Cider - or "hard cider" as it is typically known in the United States - is experiencing a real revival. The fermented apple juice with 0.5% to 7% alcohol-by-volume is the fastest growing alcohol market segment in the US, boasting a 54% increase in production annually from 2007 to 2012. Naturally, increasing consumer demand for cider translates to a need for more apples to make quality cider products.
Carol A. Miles and Jaqueline King from Washington State University's Department of Horticulture published a study in HortTechnology that can provide apple ...
An article published in the Health Affairs December issue is the first ever comprehensive analysis to investigate the Affordable Care Act's (ACA) Essential Health Benefit (EHB) as it relates to children. The study found that the EHB has resulted in a state-by-state patchwork of coverage for children and adolescents that has significant exclusions, particularly for children with developmental disabilities and other special health care needs.
Previous studies have compared the EHB standard more broadly to the Children's Health Insurance Program (CHIP), but this analysis ...
WEST LAFAYETTE, IN/ITHACA, NY - Energy costs account for one of the largest expenses in commercial greenhouse production of annual bedding plants. Naturally, bedding plant producers are searching for more energy-efficient production methods that can reduce fuel usage and increase profits. Christopher Currey, Roberto Lopez, and Neil Mattson published a study in HortTechnology that gives growers in northern latitudes valuable information on finishing practices for annual bedding plants. The researchers compared traditional heated greenhouses with unheated high tunnels for ...
(SAN FRANCISCO, December 6, 2014) - New treatment combinations and targeted therapies for lymphoma and multiple myeloma are improving outcomes for vulnerable patient populations with hard-to-treat disease, according to studies presented today at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition.
Despite advances in lymphoma treatments, improving the prognosis for patients with relapsed and treatment-resistant disease remains a challenge. The early success of several precision therapies associated with fewer side effects than conventional approaches ...
(SAN FRANCISCO, December 7, 2014) - Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in vulnerable populations, such as cancer patients.
Although significant advances have been made in the treatment and prevention of blood clots through new and improved therapies for clotting disorders, challenges remain in balancing the benefits and risks of these therapies. Specifically, while these treatments can reduce patients' risk of suffering ...
It is estimated that about 35 million people worldwide currently suffer from dementia and it is expected that the number will increase to 135 million by the year 2050. The disease is already one of the most common health problems in the elderly, which is why experts predict that the numbers of people affected will increase over time. Researchers at the Department of Psychiatry and Psychotherapy of the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently gained new insights into how it may in future be possible to treat patients with the currently ...
The ability to predict macroscopic physical and chemical properties from information derived at the micro-scale or atomic scale for various kinds of materials has yet to be perfected in the field of materials physics and chemistry. Although macro-scopic properties are determined by the micro or atomic structure of materials, it is still difficult to obtain such properties as hardness, intensity, surface tension, density, thermal expansion, thermal diffusion, viscosity and specific heat from a cell with just several atoms because of multi-scale effects.
For solids, particularly ...
